Biogened S.A. (WSE:BGD)
24.00
0.00 (0.00%)
At close: Oct 10, 2025
Biogened Market Cap
Biogened has a market cap or net worth of 58.95 million as of October 10, 2025. Its market cap has decreased by -4.00% in one year.
Market Cap
58.95M
Enterprise Value
82.51M
Revenue
112.75M
Ranking
n/a
PE Ratio
10.11
Stock Price
24.00
Market Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 58.95M, an increase of 28.81%. That is a compound annual growth rate of 1.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 58.95M | 4.35% |
Dec 30, 2024 | 56.50M | 27.78% |
Dec 29, 2023 | 44.21M | 41.73% |
Dec 29, 2022 | 31.20M | 47.67% |
Dec 30, 2021 | 21.12M | 1.18% |
Dec 30, 2020 | 20.88M | 21.43% |
Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Orlen | 102.28B |
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna | 92.03B |
Santander Bank Polska | 49.74B |
Bank Polska Kasa Opieki | 48.50B |
Powszechny Zaklad Ubezpieczen | 48.46B |
Dino Polska | 42.84B |
ING Bank Slaski | 39.62B |
mBank | 39.08B |